Literature DB >> 27324673

Epidemiology and Challenges to the Management of Advanced CKD.

Azzour D Hazzan1, Candice Halinski1, Sofia Agoritsas1, Steven Fishbane2, Maria V DeVita1.   

Abstract

Advanced CKD is a period of CKD that differs greatly from earlier stages of CKD in terms of treatment goals. Treatment during this period presents particular challenges as further loss of kidney function heralds the need for renal replacement therapy. Successful management during this period increases the likelihood of improved transitions to ESRD. However, there are substantial barriers to optimal advanced CKD care. In this review, we will discuss advanced CKD definitions and epidemiology and outcomes.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CKD; Dialysis preparation; Epidemiology

Mesh:

Year:  2016        PMID: 27324673     DOI: 10.1053/j.ackd.2016.04.005

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  5 in total

1.  Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study.

Authors:  Yoojin Noh; Jimin Lee; Sooyoung Shin; Inwhee Park; Soo Kyung Bae; Euichul Oh; Sukhyang Lee
Journal:  Int J Clin Pharm       Date:  2017-12-27

2.  Tauroursodeoxycholic acid inhibits TGF-β1-induced renal fibrosis markers in cultured renal mesangial cells by regulating endoplasmic reticulum stress.

Authors:  Li Li; Zhi-Yun Guo; Juan Wang; Pei-Pei Fei; Yan-Fei Ji; Cheng-Gang Xu
Journal:  Exp Ther Med       Date:  2022-05-09       Impact factor: 2.751

Review 3.  MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application.

Authors:  Linsey J F Peters; Jürgen Floege; Erik A L Biessen; Joachim Jankowski; Emiel P C van der Vorst
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

4.  Causes of Hospitalization among End-Stage Kidney Disease Cohort before and after Hemodialysis.

Authors:  Hsiu-Lan Li; Pei-Hui Tai; Yi-Ting Hwang; Shih-Wei Lin; Li-Ching Lan
Journal:  Int J Environ Res Public Health       Date:  2022-08-18       Impact factor: 4.614

Review 5.  The Effectiveness of Pharmacist Interventions in the Management of Patient with Renal Failure: A Systematic Review and Meta-Analysis.

Authors:  Magdalena Jasińska-Stroschein
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.